The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

Overview of attention for article published in Kidney International, November 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
blogs: 2 blogs
policy: 1 policy source
twitter: 182 X users
patent: 1 patent
facebook: 3 Facebook pages

f1000: 1 research highlight platform
video: 1 YouTube creator
guideline: 1 clinical guideline source
bluesky: 3 Bluesky users
podcasts: 1 podcast

Readers on

mendeley: 138 Mendeley

So far, Altmetric has seen 5 public wall posts from 3 users.

The International Society of Nephrology (ISN), 28 Apr 2021

Join Manuel Praga on this month's Kidney International's 𝗩𝗶𝗱𝗲𝗼 𝗔𝗯𝘀𝘁𝗿𝗮𝗰𝘁 available at the ISN Academy: The STARMEN trial…

The International Society of Nephrology (ISN), 23 Apr 2021

📖 This weekend don't miss our Kidney International #ISNFridaySelection: The STARMEN trial indicates that alternating treatment…

The International Society of Nephrology (ISN), 26 Mar 2021

⚠ Kidney International April issue is out! Read the latest news in research, highlights from current literature, comprehensive…

American Society of Pediatric Nephrology, 09 Nov 2020

The #STARMEN trial indicates that alternating treatment with #corticosteroids and# cyclophosphamide is superior to sequential…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 1 additional Facebook posts.